Efficacy and Safety of Upadacitinib in TNFi-IR Patients with Rheumatoid Arthritis from Three Phase 3 Clinical Trials

被引：0

作者：

Fleischmann, Roy ^{[1
,2
]}

Bessette, Louis ^{[3
]}

Sparks, Jeffrey ^{[4
,5
]}

Hall, Stephen ^{[6
]}

Jain, Manish ^{[7
]}

Kakehasi, Adriana ^{[8
]}

Song, Yanna ^{[9
]}

Meerwein, Sebastian ^{[10
]}

DeMasi, Ryan ^{[9
]}

Suboticki, Jessica ^{[11
]}

Rubbert-Roth, Andrea ^{[12
]}

机构：

[1] Univ Texas South Western Med Ctr, Dallas, TX USA

[2] Metroplex Clin Res Ctr, Dallas, TX USA

[3] Ctr Ostoporose & Rhumatol Quebec, Quebec City, PQ, Canada

[4] Brigham & Womens Hosp, Boston, MA USA

[5] Harvard Med Sch, Boston, MA USA

[6] Emeritus Res & Monash Univ, Melbourne, Australia

[7] Great Lakes Clin Trials, Chicago, IL USA

[8] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil

[9] AbbVie Inc, N Chicago, IL USA

[10] AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany

[11] AbbVie Inc, Mettawa, IL USA

[12] Cantonal Clin St Gallen, Div Rheumatol, St Gallen, Switzerland

来源：

ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0282

引用

页码：541 / 543

页数：3

共 50 条

[41] Effect of Filgotinib on Pain in Patients With Rheumatoid Arthritis: Results from Phase 3 Clinical Trials
Pope, Janet
Taylor, Peter
Kavanaugh, Arthur
Nash, Peter
Bartok, Beatrix
Hasegawa, Ken
Rao, Shangbang
Strengholt, Sander
Westhovens, Rene
JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1173 - 1173
[42] Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies
Xenofon Baraliakos
Roberto Ranza
Andrew Östör
Francesco Ciccia
Laura C. Coates
Simona Rednic
Jessica A. Walsh
Kevin Douglas
Tianming Gao
Koji Kato
In-Ho Song
Fabiana Ganz
Atul Deodhar
Arthritis Research & Therapy, 25
[43] The safety and efficacy of rituximab in patients with rheumatoid arthritis outside clinical trials: real life experience
Dass, S.
Vital, E. M.
Bingham, S. J.
Emery, P.
RHEUMATOLOGY, 2006, 45 : I47 - I47
[44] SAFETY OF LEFLUNOMIDE IN RHEUMATOID ARTHRITIS; FROM CLINICAL TRIALS TO CLINICAL PRACTICE
Hassan, Al
Galarraga, B.
Jordan, K. M.
Armstrong, R. D.
RHEUMATOLOGY, 2003, 42 : 98 - 98
[45] Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials
Tanaka, Yoshiya
Atsumi, Tatsuya
Amano, Koichi
Harigai, Masayoshi
Ishii, Taeko
Kawaguchi, Osamu
Rooney, Terence P.
Akashi, Naotsugu
Takeuchi, Tsutomu
MODERN RHEUMATOLOGY, 2018, 28 (04) : 583 - 591
[46] Effect of BMI on Baricitinib Efficacy: Pooled Analysis from Two Phase 3 Rheumatoid Arthritis Clinical Trials
Zerbini, Cristiano A. F.
Muram, David
Arora, Vipin K.
Alam, Jahangir
Curtis, Jeffrey R.
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[47] Comparison of the efficacy and safety of tofacitinib and upadacitinib in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials
Song, Gwan Gyu
Choi, Sung Jae
Lee, Young Ho
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (08) : 1563 - 1571
[48] COMPARISON OF THE EFFICACY AND SAFETY OF TOFACITINIB AND UPADACITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: A BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Lee, Young Ho
Song, Gwan Gyu
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 751 - 751
[49] IMPACT OF RACE ON THE EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF PHASE 2, 3 AND 3B/4 CLINICAL TRIALS
Wright, G. C.
Mysler, E.
Chen, Y. H.
Kinch, C.
Yndestad, A.
Kwok, K.
Cadatal, M. J.
Germino, R.
Ogdie, A.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 609 - 609
[50] EFFICACY AND SAFETY OF SARILUMAB IN SUBGROUPS OF PATIENTS WITH RHEUMATOID ARTHRITIS FROM 2 PHASE-3 STUDIES
Genovese, M. C.
Fleischmann, R.
Mangan, E. K.
Iglesias-Rodriguez, M.
Huizinga, T. W. J.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S68 - S69

← 1 2 3 4 5 →